HHS unified agenda
This article was originally published in The Tan Sheet
Executive Summary
FDA will begin reviewing nutrient content "high potency" and "antioxidant" claims this month and plans to complete the work in September 2007, according to the Health & Human Services Department's semi-annual "unified agenda" published in the Dec. 11 Federal Register. FDA also plans to publish a final rule on claims antihistamines can make for the common cold in June 2007, according to the unified agenda. The agency will announce a notice of proposed rulemaking in October 2007 to add Stevens-Johnson warnings on OTC analgesics. It intended to issue the proposed rule in June 2006, according to the previous unified agenda (1"The Tan Sheet" May 15, 2006, p. 8). FDA plans to issue an NPRM in May to "address oral healthcare products used to reduce or prevent dental plaque or gingivitis," the agenda says...
You may also be interested in...
FDA Agenda Slates Stevens-Johnson Proposal For June; GMPs In December?
FDA intends to issue a proposed rule to add a warning about Stevens-Johnson Syndrome to the NSAID allergy label in June, the agency announces in HHS' semi-annual "unified agenda.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.